Literature DB >> 17324573

Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.

Robert Aquaron1, Jean-Louis Bergé-Lefranc, Jean-Francois Pellissier, Marie-France Montfort, Michèle Mayan, Dominique Figarella-Branger, Michelle Coquet, Georges Serratrice, Jean Pouget.   

Abstract

We report on 31 patients and 3 affected siblings (17 males and 17 females) from Southern France with McArdle disease (two from Spanish and three from Portuguese background). Molecular analysis revealed the presence of five previously described mutations: the common p.R50X nonsense mutation, the p.R94W and p.V456M missense mutations, the p.K609K conservative mutation which generates an aberrant splicing, and the p.K754fs frameshift mutation; and 10 new molecular defects: eight missense mutations at homozygous (p.G136D) or heterozygous state (p.T379M, p.G449R, p.T488I, p.R490Q, p.R570Q, p.R590H, and p.R715W), one nonsense mutation p.R650X and one deletion (p.delK170). Our results confirm that the p.R50X nonsense mutation is also the most common associated with myophosphorylase deficiency in the Southern French population: 21 of 25 French unrelated patients (15 homozygous and six heterozygous, i.e., 72% of the mutated alleles). Two patients, one from Algeria and one from Tunisia, were homozygous for a previously identified missense mutation p.V456M in a Moroccan subject. Our findings further demonstrate molecular heterogeneity of myophosphorylase deficiency, absence of genotype-phenotype correlation and expand the already crowded map of mutations within the myophosphorylase gene. Our study also provides evidence for increased medical interest of malignant hyperthermia susceptibility (MHS) because of 34 McArdle disease patients, three and two affected siblings were contracture-tested and found to be positive.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17324573     DOI: 10.1016/j.nmd.2006.12.014

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  7 in total

1.  The pathogenomics of McArdle disease--genes, enzymes, models, and therapeutic implications.

Authors:  Gisela Nogales-Gadea; Alfredo Santalla; Astrid Brull; Noemi de Luna; Alejandro Lucia; Tomàs Pinós
Journal:  J Inherit Metab Dis       Date:  2014-07-23       Impact factor: 4.982

2.  Diagnostic evaluation of rhabdomyolysis.

Authors:  Jessica R Nance; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2015-03-14       Impact factor: 3.217

3.  A novel compound heterozygous mutation in PYGM gene associated with McArdle's disease.

Authors:  Salvatore Iacono; Antonino Lupica; Vincenzo Di Stefano; Eugenia Borgione; Filippo Brighina
Journal:  Acta Myol       Date:  2022-03-31

4.  Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update.

Authors:  Alfredo Santalla; Gisela Nogales-Gadea; Alberto Blázquez Encinar; Irene Vieitez; Adrian González-Quintana; Pablo Serrano-Lorenzo; Inés García Consuegra; Sara Asensio; Alfonsina Ballester-Lopez; Guillem Pintos-Morell; Jaume Coll-Cantí; Helios Pareja-Galeano; Jorge Díez-Bermejo; Margarita Pérez; Antoni L Andreu; Tomàs Pinós; Joaquín Arenas; Miguel A Martín; Alejandro Lucia
Journal:  BMC Genomics       Date:  2017-11-14       Impact factor: 3.969

5.  Absence of p.R50X Pygm read-through in McArdle disease cellular models.

Authors:  Guillermo Tarrasó; Alberto Real-Martinez; Marta Parés; Lídia Romero-Cortadellas; Laura Puigros; Laura Moya; Noemí de Luna; Astrid Brull; Miguel Angel Martín; Joaquin Arenas; Alejandro Lucia; Antoni L Andreu; Jordi Barquinero; John Vissing; Thomas O Krag; Tomàs Pinós
Journal:  Dis Model Mech       Date:  2020-01-13       Impact factor: 5.758

6.  Creation and implementation of a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC registry).

Authors:  Tomàs Pinós; Antoni L Andreu; Claudio Bruno; Georgios M Hadjigeorgiou; Ronald G Haller; Pascal Laforêt; Alejandro Lucía; Miguel A Martín; Andrea Martinuzzi; Carmen Navarro; Piraye Oflazer; Jean Pouget; Ros Quinlivan; Sabrina Sacconi; Renata S Scalco; Antonio Toscano; John Vissing; Matthias Vorgerd; Andrew Wakelin; Ramon Martí
Journal:  Orphanet J Rare Dis       Date:  2020-10-15       Impact factor: 4.123

Review 7.  Preclinical Research in McArdle Disease: A Review of Research Models and Therapeutic Strategies.

Authors:  Mónica Villarreal-Salazar; Astrid Brull; Gisela Nogales-Gadea; Antoni L Andreu; Miguel A Martín; Joaquín Arenas; Alfredo Santalla; Alejandro Lucia; John Vissing; Thomas O Krag; Tomàs Pinós
Journal:  Genes (Basel)       Date:  2021-12-28       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.